CFO appointment
Profound Medical Corp. appoints Matthew Sobczyk as CFO
Profound Medical Corp. reported in a Form 8-K filed November 12, 2026 that Matthew Sobczyk was appointed Chief Financial Officer, effective November 5, 2026.
In the filing's words
On November 5, 2026, the Company announced that Matthew Sobczyk has been appointed by the Board to serve as the Chief Financial Officer of the Company, effective as of the same date.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Profound Medical Corp. (PROF) |
|---|---|
| Event | Appointment |
| Incoming | Matthew Sobczyk |
| Title in the filing | Chief Financial Officer |
| Effective | November 5, 2026 |
| 8-K filed | November 12, 2026 |
| Internal promotion | Yes |
| Prior role (per filing) | Interim Chief Financial Officer, Profound Medical Corp. |
| SEC CIK | 0001628808 |
Profound Medical Corp. reported this change in a Form 8-K, Item 5.02, filed November 12, 2026. The filing's own words are quoted above.
Also filed in November 2026
Other CFO moves on the record that month. All moves.
2 days ago· 2026-11-13InterimCVLT
Commvault Systems, Inc. names Danielle Abrahamsen interim CFO
2 days ago· 2026-11-13TransitionIONQ
IonQ, Inc. CFO transition: Gary Merrill to succeed Inder M. Singh
2 days ago· 2026-11-13DepartureRGS
Regis Corporation discloses CFO departure: Kersten Zupfer
3 days ago· 2026-11-12TransitionHUBS
HubSpot, Inc. CFO transition: Karen Burgess to succeed Kate Bueker
3 days ago· 2026-11-12TransitionQXO
QXO, Inc. CFO transition: Dev Ahuja to succeed Ihsan Essaid
3 days ago· 2026-11-12DepartureRMCF
Rocky Mountain Chocolate Factory, Inc. discloses CFO departure: Carrie E. Cass
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-11-12
Something wrong about Matthew Sobczyk? Send a correction with the primary source.